REFERENCES
- Xuwu G, Chupeng C, Yizhong W. The clinical significance of plasma N-terminal brain natriuretic peptide level in chronic kidney disease patients accompanied by heart failure without dialysis. Hebei Med. 2009;15(9):1015–1018.
- Sherer Y, Shoenfeld Y. Mechanisms of disease: Atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol. 2006;2(2):99–106.
- DeLoach SS, Townsend RR. Vascular stiffness: Its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008;3(1):184–192.
- Zhang J, Hua G, Zhang X, . Regulatory T cells/T-helper cell 17 functional imbalance in uremic patients on maintenance hemodialysis: A pivotal link between microinflammation and adverse cardiovascular events. Nephrology. 2010;15(1):33–41.
- Sharma UK, Song HF, Willingham FF, . Diagnosis of human immunodeficiency virus infection using citrated whole blood. Clin Diagn Lab Immunol. 1997;4(3):261–263.
- Carrero JJ, Yilmaz MI, Lindholm B, . Cytokine dysregulation in chronic kidney disease: How can we treat it? Blood Purif. 2008;26(3):291–299.
- Mucida D, Park Y, Kim G, . Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317(5835):256–260.
- Sakaguchi S, Ono M, Setoguchi R, . Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212(1):8–27.
- Mor A, Planer D, Luboshits G, Afek A, . Role of naturally occurring CD4+CD25+ regulatory T cell in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(4):893–900.
- Csiszar A, Ungvari Z. Synergistic effects of vascular IL-17 and TNF-a may promote coronary artery disease. Med Hypotheses. 2004;63(4):696–698.
- Abdulahad WH, Stegeman CA, Limburg PC, . Skewed distribution of Th17 lymphocytes in patients with Wegener’s granulomatosis in remission. Arthritis Rheum. 2008;58(7):2196–2205.
- de Boer OJ, van der Meer JJ, Teeling P, . Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol. 2009;220(4):499–508.
- Chen S, Crother TR, Arditi M. Emerging role of IL-17 in atherosclerosis. J Innate Immun. 2010;2(4):325–333.
- Cheng X, Yu X, Ding Y, . The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127(1):89–97.
- Covic A, Kanbay M, Voroneanu L, . Vascular calcification in chronic kidney disease. Clin Sci. 2010;119(3):111–121.
- Negri AL. Vascular calcification in chronic kidney disease: Are these new treatments? Curr Vasc Pharmacol. 2005;3(2):181–184.
- Toussaint ND, Lau KK, Strauss BJ, . Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant. 2008;23(2):586–593.
- Csiszar A, Smith KE, Koller A, . Regulation of bone morphogenetic protein-2 expression in endothelial cells: Role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation. 2005;111(18):2364–2372.
- Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005;97(2):105–114.
- Hauburger A, von Einem S, Schwaerzer GK, . The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. FEBS J. 2009;276(21):6386–6398.
- Liao XB, Zhou XM, Li JM, . Taurine inhibits osteoblastic differentiation of vascular smooth muscle cells via the ERK pathway. Amino Acids. 2008;34(4):525–530.
- Al-Aly Z, Shao JS, Lai CF, . Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol. 2007;27(12):2589–2596.